Esra Cosar
About Esra Cosar
Esra Cosar is the Associate Director of Commercial Analytics - Oncology at Beigene, with a background in sales operations and analytics from companies like Genentech and Gilead Sciences.
Current Title and Role
Esra Cosar is currently the Associate Director of Commercial Analytics in the Oncology division at Beigene. She has been serving in this role since May 2019. Her work is based in Cambridge, Massachusetts, United States, where she focuses primarily on secondary data analysis and reporting within the oncology sector.
Previous Positions at Genentech
Before joining Beigene, Esra Cosar held several positions at Genentech. She worked as the Squad Lead of Sales Operations for Rheumatology from 2018 to 2019. Prior to that, she was the Senior Manager of Sales Operations for Asthma and CIU in 2016. Both roles were located in South San Francisco, California, United States.
Roles at Gilead Sciences
Esra Cosar also has extensive experience from her time at Gilead Sciences. She served as Manager of Sales Analytics for HIV from 2012 to 2015, and previously worked as Associate Manager of Business Analytics for HBV from 2010 to 2012. Her tenure at Gilead Sciences was based in Foster City, California, United States.
Consulting Experience
Esra Cosar's career includes a significant period in consulting. She worked as a consultant at Deloitte in New York from 2008 to 2010. Prior to that, she began her professional journey as an Associate Consultant at ZS Associates in Evanston, Illinois, from 2005 to 2008.
Educational Background
Esra Cosar studied Industrial Engineering at the University at Buffalo, where she achieved a Master of Science degree from 2003 to 2005. Before that, she completed her Bachelor of Science degree in Industrial Engineering at Middle East Technical University from 1999 to 2003.
Expertise and Specializations
Esra Cosar has specialized knowledge in several key areas, including sales force sizing and structure, territory alignments, patient and HCP segmentation, targeting, call planning, and incentive compensation. Her expertise is particularly concentrated in secondary data analysis and reporting within the oncology field.